1.The effect of topical inhalant steroids(Budesonide, pulmicort@) in treatment of intubation granuloma.
Soo Geun WANG ; Kyong Myong CHON ; In Kyu YOON ; Dong Kyun KIM ; Sang Hwa LEE ; Won Ju PARK ; Jong Cheol LEE
Korean Journal of Otolaryngology - Head and Neck Surgery 1992;35(1):183-190
No abstract available.
Granuloma*
;
Intubation*
2.Effects of Substance P on the Cell Proliferation and IL-2 Production of T Lymphocyte.
Jin Kyun MOON ; Byung Son CHOI ; Seok Cho LEE ; Hyung Seop KIM
The Journal of the Korean Academy of Periodontology 1997;27(4):805-818
Immune responses of periodontal tissue may be regulated by products of sensory afferent nerve endings such as neuropeptides. Substance P(SP), a tachykinin neuropeptide, has been previously reported to stimulate the activities of T lymphocyte. Therefore, I examined the role of SP in IL-2 production and cell proliferation by using a homogeneous line of T lymphocytes(Jurkat and HuT78). Cell proliferation rate was determined by [3H]-thymidine incorporation test, and IL-2 was quantitated by the growth rate of CD4+ IL-2-dependent T lymphocyte line CTLL-2. SP stimulated cell proliferation of T lymphocytes at the concentration of 10(-12) and 10(-8)M in a biphasic bell-shape dose-dependent manner. However, SP alone did not induce IL-2 release at the concentration range of 10(-6) to 10(-14)M. The upregulation of IL-2 release was observed when 10(-12)M SP was applied together with mitogens such as Con A or PHA+PMA on T cell lines, especially on Jurkat. Con A or PHA+PMA demonstrated to increase the rate of cell proliferation of Jurkat, which had shown to produce much amount of IL-2 indicating that mitogen-induced cell proliferation might be partially influenced by released IL-2. It was concluded that regulatory effects of SP on the immune/inflammatory response could be mediated through the costimulatory upregulation of IL-2 production and increase of cell proliferation of T lymphocyte.
Cell Line
;
Cell Proliferation*
;
Interleukin-2*
;
Lymphocytes*
;
Mitogens
;
Nerve Endings
;
Neuropeptides
;
Substance P*
;
T-Lymphocytes
;
Tachykinins
;
Up-Regulation
3.Changes in Hemodynamics and Plasma Catecholamine Levels following Midazolam Premedication.
Jin Young CHON ; Jeong Hwan CHOI ; In CHAE ; Yu Jin KANG ; Ho Geong SONG ; Sung Kyun LEE
Korean Journal of Anesthesiology 1994;27(3):236-245
The present study atternpted. to expiore the new benzodiazepine, midazolam, which is water-soluble, shorter-acting, more potent, and less irritating to inject than diazepam, and which has been used as premedication before induction of anesthesia in various elective surgeries. Forty patients (aged 20 to 50 and in ASA class I or II ) about to undergo simple elective surgery under general anesthesia entered the study. The patients were divided into the study group (n=20) that recieved 0.07 mg/Kg i.m midazolan premedication and the control group (n= 20) that recieved normal saline as sham premedication. The changes in the values of various hemodynamic parameters, i.e., heart rate and systolic, diastolic, mean arterial pressures, were monitored first before tracheal intubation, then at the time of intubation and 5, 10 and 30 minutes after intubation. The concentrations of plasma catecholamines i.e., epinephrine and norepinephrine, were measured before intubation and 5, 30 minutes after intubation. Systolic pressure and plasma epinephrine concentration before induction was significantly low in the study compared with the controls. At the time of intubation, sytolic, diastolic & mean arterial pressures were significantly low in the study group compared with the controls. Heart rates measured at 10 and 30 minutes postintubation were significantly low at 30 minutes postintubation in the study group compared with the controls as was plasma epinephrine levels at each instance of its measurement. In conclusion, midazolam-premedicated patients appear to maintain stable hemodynamies and plasma catecholamine levels. Our findings support that midazolam premedication effectively reduces stress response during induction period making it suitable induction for elective surgery.
Anesthesia
;
Anesthesia, General
;
Arterial Pressure
;
Benzodiazepines
;
Blood Pressure
;
Catecholamines
;
Diazepam
;
Epinephrine
;
Heart Rate
;
Hemodynamics*
;
Humans
;
Intubation
;
Midazolam*
;
Norepinephrine
;
Plasma*
;
Premedication*
4.Cortical Volumetric Correlates of Childhood Trauma, Anxiety, and Impulsivity in Bipolar Disorder
Hyehyun SONG ; Myong-Wuk CHON ; Vin RYU ; Rina YU ; Dong-Kyun LEE ; Hyeongrae LEE ; Wonhye LEE ; Jung Hyun LEE ; Dong Yeon PARK
Psychiatry Investigation 2020;17(7):627-635
Objective:
More recently, attention has turned to the linkage between childhood trauma and emotional dysregulation, but the evidence in bipolar disorder (BD) is limited. To determine neurobiological relationships between childhood trauma, current anxiety, and impulsivity, we investigated cortical volumetric correlates of these clinical factors in BD.
Methods:
We studied 36 patients with DSM-5 BD and 29 healthy controls. Childhood trauma, coexisting anxiety, and impulsivity were evaluated with the Korean version-Childhood Trauma Questionnaire (CTQ), the Korean version-Beck Anxiety Inventory (BAI), and the Korean version-Barratt Impulsiveness Scale (BIS). Voxel-based morphometry (VBM) was used to assess gray matter volume (GMV) alterations on the brain magnetic resonance imaging (MRI). Partial correlation analyses were conducted to examine associations between the GMV and each scale in the BD group.
Results:
Childhood trauma, anxiety, and impulsivity were interrelated in BD. BD patients revealed significant inverse correlations between the GMV in the right precentral gyrus and CTQ scores (r=-0.609, p<0.0003); between the GMV in the left middle frontal gyrus and BAI scores (r=-0.363, p=0.044). Moreover, patients showed similar tendency of negative correlations between the GMV in the right precentral gyrus and BIS scores; between the GMV in the left middle frontal gyrus and CTQ scores.
Conclusion
The present study provides evidence for a neural basis between childhood trauma and affect regulations in BD. The GMV alterations in multiple frontal lobe areas may represent neurobiological markers for anticipating the course of BD.
5.Comparison of Somatostatin and Vasopressin in the Control of Acute Esophageal Variceal Hemorrhage: A Prospective Randomized Trial.
Chae Yoon CHON ; Jeong Il JEONG ; Yong Han PAIK ; Chun Kyun LEE ; Byung Hyun CHOE ; Kwan Sik LEE ; Byung Soo MOON ; Kwang Hyub HAN ; Young Myoung MOON ; Dong Kee KIM
The Korean Journal of Hepatology 2000;6(4):468-473
BACKGROUND/AIMS: Although endoscopic band ligation or injection sclerotherapy are the current standard therapies for bleeding esophageal varices, the best method for initial control is unclear. The aim of this prospective study was to compare the efficacy and toxicity of somatostatin and vasopressin in the management of esophageal variceal hemorrhage. METHODS: From March, 1997 to September, 1998, 28 consecutive cirrhotic patients admitted to the Yonsei Medical Center because of active variceal bleeding were included in this trial. The patients were randomized to receive either somatostatin (15 patients) or vasopressin (13 patients) for 48 hours. RESULTS: There were no significant differences between the two treatment groups in relation to Child's classification, amount of bleeding before randomization and units of blood transfused during therapy. Initial control of bleeding was achieved in 13 (86.7%) patients receiving somatostatin and in 10 (76.9%) of those treated with vasopressin. However, two patients in the somatostatin group and two in the vasopressin group bled again during treatment. Therefore complete control of bleeding during the 48 hours of therapy was achieved in 11 (73.4%) patients treated with somatostatin and in eight (61.5%) of those receiving vasopressin. Differences were observed in complications associated with each therapy. Vasopressin produced complications in four patients (chest pain in two, hypertension in one and hyponatremia-induced seizure in one) while somatostatin produced minor complication in one patient. CONCLUSIONS: This study suggests that somatostatin is efficacious in controlling acute hemorrhage from esophageal varices and has a lower risk of adverse effects than vasopressin.
Classification
;
Esophageal and Gastric Varices
;
Hemorrhage*
;
Humans
;
Hypertension
;
Ligation
;
Prospective Studies*
;
Random Allocation
;
Sclerotherapy
;
Seizures
;
Somatostatin*
;
Vasopressins*
6.A Case of Mitral Regurgitation due to Windsock Deformity with Perforations of the Anterior Mitral Leaflet-a Late Complication of Endocarditis.
Yeon Ah LEE ; Jin Hyuk KIM ; Sang Hoon LEE ; Suk CHON ; Dal Soo LIM ; Seung Mook JUNG ; Rack Kyun CHOI ; Seok Keun HONG ; Hweung Kon HWANG
Korean Circulation Journal 2003;33(4):333-337
A valvular perforation is a well-known, and common, complication of infective endocarditis that may adversely affect the clinical outcome. However, a 'windsock' deformity of the mitral valve, as a delayed presentation of infective endocarditis, affecting the mitral valve alone, is very rare. A 42-year-old man, who underwent a mitral valvuloplasty and annuloplasty six years previously, suddenly developed pulmonary edema. He had also had a previous history of infective endocarditis, dating back three years. A transthoracic echocardiogram revealed a 'windsock' deformity of the anterior mitral leaflet (AML), resulting in an acute severe mitral regurgitation. During the operation, the AML was found to have been damaged by the previous endocarditis, resulting in an aneurysmal change of the central scallop, and a rupture of the roof. A mitral valve replacement was successfully performed, and the patient recovered uneventfully. Here, we report a rare case of a 'windsock' deformity of the mitral valve, with two perforations as a delayed complication of a healed infective endocarditis.
Adult
;
Aneurysm
;
Congenital Abnormalities*
;
Endocarditis*
;
Humans
;
Mitral Valve
;
Mitral Valve Insufficiency*
;
Pectinidae
;
Pulmonary Edema
;
Rupture
7.A Case Report of Thymic Carcinoid Tumor Associated with Cushing's Syndrome: Possible Corticotropin-Releasing Hormone Secreting Tumor.
Soon Ho CHON ; Chul Burm LEE ; Sun Kyun RO ; Young Ha OH ; Jun Goo KANG ; Jong Hoon YEOM
The Korean Journal of Thoracic and Cardiovascular Surgery 2006;39(10):795-798
Thymic carcinoid tumor associated with Cushing's syndrome is a rare disease with a poor prognosis. Thymic carcinoid with Cushing's syndrome caused by CRH (corticotropin-releasing hormone) production is even rarer. We report a 58-year-old woman with a huge anterior mediastinal mass. Five months after thymectomy the patient was readmitted with symptoms of generalized edema and dyspnea. Recurrence and metastases were discovered and Cushing's syndrome diagnosed.
Carcinoid Tumor*
;
Corticotropin-Releasing Hormone*
;
Cushing Syndrome*
;
Dyspnea
;
Edema
;
Female
;
Humans
;
Middle Aged
;
Neoplasm Metastasis
;
Prognosis
;
Rare Diseases
;
Recurrence
;
Thymectomy
;
Thymus Gland
8.A Case of Hepatocellular Carcinoma Within Hepatocellular Adenoma in a Non-Cirrhotic Male.
Dong Hwan KIM ; Seung Up KIM ; Dong Hyuk NAM ; Yoon Jung CHOI ; Soo Mi PARK ; Chon Kyun LEE ; Do Young KIM
The Korean Journal of Internal Medicine 2009;24(2):147-152
Hepatocellular adenoma (HA) is a benign hepatic lesion that predominantly occurs in young women. Most hepatocellular carcinomas (HCC) arise in a cirrhotic liver during the fifth or sixth decades. There have been several reported cases of HCC developing from HA in female patients. However, there are rare cases about HCC arising in HA in a non-cirrhotic male patient. We have recently encountered a 53-year-old man who had a liver mass in a non-cirrhotic liver, and the liver mass was compatible with HA on the pre-operative computed tomography. The mass was completely resected and the histopathology revealed a focus of HCC arising in HA. We report here on this case along with a brief review of the relevant literature
Adenoma, Liver Cell/*pathology/surgery
;
Adult
;
Biopsy
;
Carcinoma, Hepatocellular/*pathology/surgery
;
Female
;
Hepatectomy
;
Humans
;
Liver Neoplasms/*pathology/surgery
;
Male
;
Middle Aged
;
Precancerous Conditions/*pathology/surgery
;
Tomography, X-Ray Computed
;
Treatment Outcome
;
Ultrasonography
;
Young Adult
9.Hepatocellular Carcinoma in Korea Between 2008 and 2011: an Analysis of Korean Nationwide Cancer Registry
Jun Sik YOON ; Han Ah LEE ; Jun Yong PARK ; Bo Hyun KIM ; In Joon LEE ; Young Eun CHON ; Suk Kyun HONG ; Dong Hyeon LEE ; Hyun-Joo KONG ; Young-Joo WON ; Eunyang KIM ; Jeong-Hoon LEE
Journal of Liver Cancer 2020;20(1):41-52
Background:
s/Aims: Backgrounds/Aims: In Korea, hepatocellular carcinoma (HCC) is the sixth most common cancer and results in the second-highest cancer death rate among all cancers. We aimed to describe the characteristics of patients who were newly diagnosed with HCC in Korea between 2008 and 2011.
Methods:
The Korean Primary Liver Cancer Registry (KPLCR) is a random sample consisting of approximately 15% of patients with newly diagnosed primary liver cancer registered in the Korean Central Cancer Registry. We investigated the baseline characteristics, treatment modalities, and overall survival (OS) of patients with HCC registered in the KPLCR between 2008 and 2011.
Results:
A total of 6,083 patients were histologically or radiologically diagnosed with HCC. The hepatitis B virus was the predominant HCC etiology (72.0%). According to the Barcelona Clinic Liver Cancer (BCLC) staging system, stages 0, A, B, C, and D accounted for 8.6%, 39.7%, 11.5%, 33.8%, and 6.9%, respectively. Transarterial therapy (41.7%) was the most commonly performed initial treatment, followed by best supportive care (21.7%), surgical resection (16.7%), and local ablation therapies (10.6%). The overall rate of adherence to the BCLC treatment guideline was only 37.7%. The 1-, 3-, and 5-year OS rates were 65.6%, 46.2%, and 36.8%, respectively.
Conclusions
Between 2008 and 2011, approximately half of patients with HCC (48.3%) were candidates for curative treatment (BCLC stage 0 or A), but one-third of patients (33.8%) had advanced HCC (BCLC stage C). Transarterial therapy was the most commonly conducted initial treatment and the 5-year OS rate was 36.8% in this period.
10.Hepatocellular Carcinoma in Korea between 2012 and 2014: an Analysis of Data from the Korean Nationwide Cancer Registry
Young Eun CHON ; Han Ah LEE ; Jun Sik YOON ; Jun Yong PARK ; Bo Hyun KIM ; In Joon LEE ; Suk Kyun HONG ; Dong Hyeon LEE ; Hyun-Joo KONG ; Eunyang KIM ; Young-Joo WON ; Jeong-Hoon LEE
Journal of Liver Cancer 2020;20(2):135-147
Background/Aims:
Considering the high prevalence and mortality of hepatocellular carcinoma (HCC) in Korea, accurate statistics for HCC are important. We evaluated the characteristics of Korean patients with newly diagnosed HCC.
Methods:
We retrospectively evaluated data from the Korean Primary Liver Cancer Registry (KPLCR). The baseline characteristics, treatment modalities, and overall survival (OS) of 4,572 patients with HCC registered in the KPLCR between 2012 and 2014 were investigated.
Results:
At the time of HCC diagnosis, the median age was 60.0 years, with male predominance (79.6%). Hepatitis B virus infection was the most common etiology (59.1%). The rates of Barcelona Clinic Liver Cancer (BCLC) stages 0, A, B, C, and D at diagnosis were 3.9%, 36.9%, 12.5%, 39.4%, and 7.3%, respectively. The proportion of very early or early stage HCC at diagnosis (BCLC stage 0 or A) in the 2012-2014 cohort was significantly lower than that in the 2008-2011 cohort (40.8% vs. 48.3%, P<0.001). Transarterial therapy (37.5%) was the most commonly performed initial treatment, followed by surgical resection (19.8%), best supportive care (19.1%), and local ablation (10.6%). The median OS was 2.9 years, and the 1-, 3-, and 5-year OS rates were 67.7%, 49.3% and 41.9%, respectively. The OS rate of the 2012-2014 cohort was significantly higher than that of the 2008-2011 cohort (log-rank, P<0.001).
Conclusions
The OS of HCC patients registered in the KPLCR between 2012 and 2014 significantly improved. Nevertheless, as about half of the HCC patients were diagnosed at an advanced stage, vigorous and optimized HCC screening strategies should be implemented.